rs142981913

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001171613.2(PREPL):​c.450A>C​(p.Lys150Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

PREPL
NM_001171613.2 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.222

Publications

0 publications found
Variant links:
Genes affected
PREPL (HGNC:30228): (prolyl endopeptidase like) The protein encoded by this gene belongs to the prolyl oligopeptidase subfamily of serine peptidases. Mutations in this gene have been associated with hypotonia-cystinuria syndrome, also known as the 2p21 deletion syndrome. Several alternatively spliced transcript variants encoding either the same or different isoforms have been described for this gene.[provided by RefSeq, Jan 2010]
PREPL Gene-Disease associations (from GenCC):
  • hypotonia-cystinuria syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • myasthenic syndrome, congenital, 22
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07309744).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PREPLNM_001171613.2 linkc.450A>C p.Lys150Asn missense_variant Exon 5 of 14 ENST00000409411.6 NP_001165084.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PREPLENST00000409411.6 linkc.450A>C p.Lys150Asn missense_variant Exon 5 of 14 1 NM_001171613.2 ENSP00000387095.2

Frequencies

GnomAD3 genomes
AF:
0.000434
AC:
66
AN:
152130
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000836
AC:
21
AN:
251220
AF XY:
0.000118
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000164
AC:
24
AN:
1461142
Hom.:
0
Cov.:
31
AF XY:
0.0000193
AC XY:
14
AN XY:
726908
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33440
American (AMR)
AF:
0.0000672
AC:
3
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39654
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111544
Other (OTH)
AF:
0.0000828
AC:
5
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000434
AC:
66
AN:
152130
Hom.:
0
Cov.:
31
AF XY:
0.000404
AC XY:
30
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.00152
AC:
63
AN:
41440
American (AMR)
AF:
0.000131
AC:
2
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68014
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000171
Hom.:
0
Bravo
AF:
0.000480
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000988
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Myasthenic syndrome, congenital, 22 Uncertain:2
Jan 23, 2023
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 06, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 239 of the PREPL protein (p.Lys239Asn). This variant is present in population databases (rs142981913, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PREPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 544537). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Apr 12, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.717A>C (p.K239N) alteration is located in exon 5 (coding exon 5) of the PREPL gene. This alteration results from a A to C substitution at nucleotide position 717, causing the lysine (K) at amino acid position 239 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.030
.;.;.;T;T;T;T;.;.
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.27
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Uncertain
0.87
D;.;.;.;.;.;D;D;D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.073
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.55
.;.;.;N;N;N;N;N;N
PhyloP100
0.22
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.4
N;N;N;N;N;N;N;N;N
REVEL
Benign
0.043
Sift
Benign
0.17
T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.31
T;T;T;T;T;T;T;T;T
Polyphen
0.084, 0.99, 0.45
.;.;.;B;B;B;B;D;B
Vest4
0.55
MutPred
0.44
.;.;.;Loss of ubiquitination at K239 (P = 0.0127);Loss of ubiquitination at K239 (P = 0.0127);Loss of ubiquitination at K239 (P = 0.0127);Loss of ubiquitination at K239 (P = 0.0127);Loss of ubiquitination at K239 (P = 0.0127);Loss of ubiquitination at K239 (P = 0.0127);
MVP
0.31
MPC
0.0049
ClinPred
0.038
T
GERP RS
-2.6
Varity_R
0.058
gMVP
0.61
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142981913; hg19: chr2-44569591; API